Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

Effect of sequence dispersity on morphology of tapered diblock copolymers from molecular dynamics simulations.

Levine WG, Seo Y, Brown JR, Hall LM.

J Chem Phys. 2016 Dec 21;145(23):234907. doi: 10.1063/1.4972141.

PMID:
28010074
2.
3.

Substrates for microsomal azoreductase. Hammett substituent effects, NMR studies, and response to inhibitors.

Zbaida S, Brewer CF, Levine WG.

Drug Metab Dispos. 1992 Nov-Dec;20(6):902-8.

PMID:
1362944
4.

Multiple mechanisms in hepatic microsomal azoreduction.

Levine WG, Stoddart A, Zbaida S.

Xenobiotica. 1992 Sep-Oct;22(9-10):1111-20.

PMID:
1441602
5.

Azoreductase activity by purified rabbit liver aldehyde oxidase.

Stoddart AM, Levine WG.

Biochem Pharmacol. 1992 May 28;43(10):2227-35.

PMID:
1599508
6.

Role of electronic factors in binding and reduction of azo dyes by hepatic microsomes.

Zbaida S, Levine WG.

J Pharmacol Exp Ther. 1992 Feb;260(2):554-61.

PMID:
1738106
8.

Metabolism of azo dyes: implication for detoxication and activation.

Levine WG.

Drug Metab Rev. 1991;23(3-4):253-309. Review.

PMID:
1935573
9.
10.

Two classes of azo dye reductase activity associated with rat liver microsomal cytochrome P-450.

Levine WG, Zbaida S.

Adv Exp Med Biol. 1991;283:315-21. No abstract available.

PMID:
1906222
11.
13.
14.

Studies on the mechanism of reduction of azo dye carcinogens by rat liver microsomal cytochrome P-450.

Zbaida S, Stoddart AM, Levine WG.

Chem Biol Interact. 1989;69(1):61-71.

PMID:
2914330
16.
17.

Microsomal azoreduction and glucuronidation in the metabolism of dimethylaminoazobenzene by the rat liver.

Raza H, Levine WG, Chowdhury NR, Chowdhury JR.

Xenobiotica. 1987 Jun;17(6):669-77.

PMID:
3114967
18.

Effect of hypolipidemic drugs on the metabolism of lauric acid and dimethylaminoazobenzene by rat liver microsomes.

Raza H, Levine WG.

Biochem Pharmacol. 1987 Mar 1;36(5):774-8. No abstract available.

PMID:
3103631
19.
21.

Clofibrate selectively induces azoreduction of dimethylaminoazobenzene (DAB) by rat liver microsomes.

Levine WG, Raza H.

Adv Exp Med Biol. 1986;197:861-70. No abstract available.

PMID:
3094343
22.
24.
25.
26.

Effect of long-term administration of delta 9-tetrahydrocannabinol on hepatic mixed-function oxidase systems in the rat.

Morrill GA, O'Connell ME, Kostellow AB, Levine WG.

Pharmacology. 1985;30(1):20-4.

PMID:
2983357
28.
30.

Effect of glutathione on the metabolism of N,N-dimethyl-4-aminoazobenzene by rat liver microsomes.

Levine WG, Lee S.

Drug Metab Dispos. 1983 May-Jun;11(3):239-43.

PMID:
6135582
31.

Glutathione and hepatic mixed-function oxidase activity.

Levine WG.

Drug Metab Rev. 1983;14(5):909-30. Review.

PMID:
6418502
32.

Effect of nafenopin on the uptake of bilirubin and sulfobromophthalein by isolated perfused rat liver.

Gärtner U, Stockert RJ, Levine WG, Wolkoff AW.

Gastroenterology. 1982 Dec;83(6):1163-9.

PMID:
6751925
33.
34.
35.

Biliary excretion of drugs and other xenobiotics.

Levine WG.

Prog Drug Res. 1981;25:361-420. Review. No abstract available.

PMID:
6273968
37.

Transcriptional and translational control of nafenopin-induced ornithine decarboxylase activity in rat liver.

Lam DC, Levine WG.

Res Commun Chem Pathol Pharmacol. 1980 Apr;28(1):113-22.

PMID:
7394309
38.

Effects of adrenergic antigonists on prereplicative changes during nafenopin-induced liver growth in the rat.

Lam DC, Levine WG.

Biochem Pharmacol. 1979 Dec 15;28(24):3539-44. No abstract available.

PMID:
533557
39.

A role for liver glutathione in the hepatobiliary fate of N,N-dimethyl-4-aminoazobenzene.

Levine WG, Finkelstein TT.

J Pharmacol Exp Ther. 1979 Mar;208(3):399-405. No abstract available.

PMID:
107307
41.

Biliary excretion of drugs and other xenobiotics.

Levine WG.

Annu Rev Pharmacol Toxicol. 1978;18:81-96. Review.

PMID:
348071
42.

Metabolism and biliary excretion of NN-dimethylaminoazobenzene: a possible role for liver glutathione.

Levine WG.

Biochem Soc Trans. 1978;6(5):964-5. No abstract available.

PMID:
105947
43.

Some biochemical changes associated with nafenopin-induced liver growth in the rat.

Levine WG, Ord MG, Stocken LA.

Biochem Pharmacol. 1977 May 15;26(10):939-42. No abstract available.

PMID:
861041
44.

Biliary excretion of drugs in the rat during liver regeneration.

Uesugi T, Bognacki J, Levine WG.

Biochem Pharmacol. 1976 May 15;25(10):1187-93. No abstract available.

PMID:
938541
46.

Biliary excretion of 3,4-benzpyrene in nafenopin-treated rats.

Levine WG, Bognacki J.

J Pharmacol Exp Ther. 1976 Feb;196(2):486-92.

PMID:
1255492
47.

The influence of dehydrocholate on hepatic uptake and biliary excretion of 3H-taurocholate and 3H-ouabain.

Meijer DK, Vonk RJ, Scholtens EJ, Levine WG.

Drug Metab Dispos. 1976 Jan-Feb;4(1):1-7.

PMID:
3395
48.

Effect of hypolipidemic drugs, nafenopin and clofibrate, on the concentration of ligandin and Z protein in rat liver.

Fleischner G, Meijer DK, Levine WG, Gatmaitan Z, Gluck R, Arias IM.

Biochem Biophys Res Commun. 1975 Dec 15;67(4):1401-7. No abstract available.

PMID:
812503
49.

Effect of nafenopin (SU-13,437) on liver function: mechanism of choleretic effect.

Levine WG, Braunstein HR, Mejier DK.

Naunyn Schmiedebergs Arch Pharmacol. 1975;290(2-3):221-34.

PMID:
1186921
50.

Effect of nafenopin (SU-13,437) on liver function: influence on the hepatic transport of organic anions.

Meijer DK, Bognacki J, Levine WG.

Naunyn Schmiedebergs Arch Pharmacol. 1975;290(2-3):235-50.

PMID:
810733

Supplemental Content

Loading ...
Support Center